Savient Pharmaceuticals (SVNT) Misses All Q1 Expectations
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Financial Fact:
Loss before income taxes: -20.43M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Loss before income taxes: -20.43M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q1 EPS of ($0.49), $0.03 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $4.59 million.
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
- CoStar Group acquires Zonda for $800M, adding new home data
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
